A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family

Nature Genetics
Carole CharlierM Leppert

Abstract

Epileptic disorders affect about 20-40 million people worldwide, and 40% of these are idiopathic generalized epilepsies (IGEs; ref. 1). Most of the IGEs that are inherited are complex, multigenic diseases. To address basic mechanisms for epilepsies, we have focused on one well-defined class of IGEs with an autosomal-dominant mode of inheritance: the benign familial neonatal convulsions (BFNC; refs 2,3). Genetic heterogeneity of BFNC has been observed. Two loci, EBN1 and EBN2, have been mapped by linkage analysis to chromosome 20q13 (refs 5,6) and chromosome 8q24 (refs 7,8), respectively. By positional cloning, we recently identified the gene for EBN1 as KCNQ2 (ref. 9). This gene, a voltage-gated potassium channel, based on homology, is a member of the KQT-like family. Here we describe an additional member, KCNQ3. We mapped this new gene to chromosome 8, between markers D8S256 and D8S284 on a radiation hybrid map. We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype. The same conserved amino acid is also mutated in KVLQT1 (KCNQ1) in an LQT patient. KCNQ2,...Continue Reading

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·M B SoaresA Efstratiadis
Oct 1, 1993·Brain Pathology·M LeppertM Connolly
May 1, 1993·Genomics·H L DrwingaR A Mulivor
Jul 1, 1995·Human Molecular Genetics·F ZaraM Pandolfo
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·W P YangM A Blanar

❮ Previous
Next ❯

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·C E Stafstrom, B L Tempel
Sep 11, 1999·Annals of Neurology·H LercheO K Steinlein
Oct 8, 1999·Annals of Neurology·A PeifferM Leppert
Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·S NagamitsuM Shimada
Jun 1, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·K P BhatiaL J Ptácek
Jun 21, 2001·Annals of Neurology·X F Yang, S M Rothman
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Sian D SpaceyNicholas W Wood
Jul 2, 2003·Neurotoxicity Research·Antonio Gil-Nagel
Apr 22, 2008·The Journal of Membrane Biology·Akira UeharaKiyoko Uehara
Jan 24, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Melodie R WinawerAbraham A Palmer
Nov 13, 2012·Journal of Neurology·Snezana Maljevic, Holger Lerche
Nov 29, 2007·Pflügers Archiv : European journal of physiology·Daniel Johnson, Eric S Bennett
Apr 20, 2010·Pflügers Archiv : European journal of physiology·Snezana MaljevicHolger Lerche
Mar 18, 2004·Bioorganic & Medicinal Chemistry Letters·Piyasena HewawasamSteven I Dworetzky
Apr 9, 2013·European Journal of Pharmacology·William Dalby-BrownSusanne Jørgensen
Nov 5, 2003·Experimental Neurology·Robert L MacdonaldHuajun Feng
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah E HeronJohn C Mulley
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sanjeev RajakulendranMichael G Hanna
Apr 20, 2000·European Journal of Pharmacology·O K Steinlein
Mar 14, 2002·European Journal of Pharmacology·Delphine S DupuisSøren P Olesen
Jan 5, 2000·European Journal of Pharmacology·R HetkaD Schmitz
Aug 26, 2000·Progress in Biophysics and Molecular Biology·B S Brown, S P Yu
Jul 13, 2001·Pharmacology & Therapeutics·J Robbins
Aug 23, 2002·Pharmacology & Therapeutics·Alan Wickenden
Nov 3, 2001·Brain Research. Brain Research Reviews·B MoulardD Bertrand
Jun 6, 2000·Trends in Pharmacological Sciences·M C Sanguinetti
Aug 14, 2003·Trends in Pharmacological Sciences·Ingrid E Scheffer, Samuel F Berkovic
Sep 3, 2002·Neuroscience Research·Sunao KanekoShinichi Hirose
Oct 19, 2000·Brain Research. Molecular Brain Research·F Jow, K Wang
May 17, 2002·Brain & Development·Shinichi HiroseAkihisa Mitsudome
Jul 10, 2003·Brain & Development·Shinichi HiroseAkihisa Mitsudome
May 8, 2004·Brain & Development·Ortrud K Steinlein
Jun 23, 2000·Epilepsy Research·K MizunoS Kaneko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.